Following is my interpretation of recent market size developments:
There has been a vast expansion in Eligible FTSD (full thickness skin defects) that has been revealed by the Form 8-K released to the market on 27th June 2023.
Prior to the June approvals, Avita was guiding for a 5-6x increase in their market size for eligible FTSD procedures following approval for soft tissue. That is from just their burns market to include burns and soft tissue defects after approval for soft tissue.
Well, the Form 8-K now reveals a market size of approximately 391,000 eligible FTSD procedures due to the "FDA Approved Expanded Indication of FTSD". That is now 15-16x larger than the previous 25K burns market prior to the June approval for soft tissue.
For those more experienced in matters relating to AVH, please tell me if I have misinterpreted this.
- Forums
- ASX - By Stock
- The near term future
Following is my interpretation of recent market size...
-
- There are more pages in this discussion • 89 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVH (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.14 |
Change
0.020(0.64%) |
Mkt cap ! $221.1M |
Open | High | Low | Value | Volume |
$3.12 | $3.15 | $3.12 | $12.83K | 4.097K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 20 | $3.12 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.15 | 14187 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 2315 | 3.120 |
1 | 5173 | 3.110 |
3 | 5615 | 3.100 |
2 | 14612 | 3.090 |
2 | 28495 | 3.080 |
Price($) | Vol. | No. |
---|---|---|
3.150 | 14187 | 6 |
3.160 | 2521 | 3 |
3.170 | 11389 | 2 |
3.180 | 10333 | 2 |
3.190 | 58888 | 2 |
Last trade - 10.57am 07/10/2024 (20 minute delay) ? |
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
AVH (ASX) Chart |